Results 121 to 130 of about 1,437,202 (311)

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

Pharmacopsychiatry, 2017
C. Hiemke, N. Bergemann, H. Clement, A. Conca, J. Deckert, K. Domschke, G. Eckermann, K. Egberts, M. Gerlach, C. Greiner, G. Gründer, E. Haen, U. Havemann-Reinecke, G. Hefner, R. Helmer, G. Janssen, E. Jaquenoud, G. Laux, T. Messer, R. Mössner, Matthias J. Müller, M. Paulzen, B. Pfuhlmann, P. Riederer, A. Saria, B. Schoppek, G. Schoretsanitis, M. Schwarz, M. S. Gracia, B. Stegmann, W. Steimer, J. Stingl, M. Uhr, S. Ulrich, S. Unterecker, R. Waschgler, G. Zernig, Gabriele Zurek, P. Baumann   +38 more
semanticscholar   +1 more source

Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz, Carolin Otto, Klemens Ruprecht, Susanna Asseyer, Hannes Ole Tiedt, Christian Meisel, Judith Bellmann‐Strobl, Friedemann Paul, Patrick Schindler   +8 more
wiley   +1 more source

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy

, 2010
Guillermo Gervasini, Julio Benítez, Juan Antonio Carrillo   +2 more
openalex   +2 more sources

Nerve Excitability in Asymptomatic Carriers and Amyotrophic Lateral Sclerosis Patients With C9orf72

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We investigated the effects of C9orf72 mutation carriership on peripheral nerve excitability in asymptomatic individuals from families with a history of C9orf72 amyotrophic lateral sclerosis (ALS) and patients. Methods We included 47 asymptomatic individuals from families with a history of C9orf72 ALS, of whom 23 were carriers (C9 ...
Diederik J. L. Stikvoort García, H. Stephan Goedee, Leonard H. van den Berg, Boudewijn T. H. M. Sleutjes   +3 more
wiley   +1 more source

Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy

, 2020
Seid Hamzic, Stefan Aebi, Markus Joerger, Michael Montemurro, Marc Ansari, Ursula Amstutz, Carlo R. Largiadèr   +6 more
openalex   +2 more sources

Therapeutic drug monitoring of immunotherapies with novel Affimer–NanoBiT sensor construct

, 2023
Emma Campbell, Hope Adamson, Timothy Luxton, Christian Tiede, Christoph Wälti, Darren C. Tomlinson, Lars J. C. Jeuken   +6 more
openalex   +2 more sources

Moyamoya Disease and the Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo, Jeong‐Yong Shin, Rugyeom Lee, Jiwon Cheon, Ji Hun Kim, Doeun Kim, Jae‐Kyung Won, In‐Hwan Oh, Yunjong Lee, Tae‐Beom Ahn   +9 more
wiley   +1 more source

Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients

, 2017
Bushra Salman, Mohammed Al Za’abi, Mohammed Al-Huneini, David Dennison, Abdulhakeem Al-Rawas, Salam Alkindi, Khalil Al‐Farsi, Melanie Tauro, Murtadha Al‐Khabori   +8 more
openalex   +1 more source

Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions

, 2020
Chih‐Ning Cheng, Chien‐Chih Wu, Ching‐Hua Kuo, Chi‐Chuan Wang, Jann‐Tay Wang, Ya‐Ting Lin, Ren-Shiang Jhang, Shu‐Wen Lin   +7 more
openalex   +1 more source

On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring [PDF]

, 2015
Barbara Sanavio, Silke Krol
openalex   +1 more source